Future studies are needed to establish cutoff values for vascular biomarkers that could improve cardiovascular outcomes in hypertensive patients.
Can vascular biomarkers be used in hypertension management to improve cardiovascular outcomes?
Current guidelines lack clear reference values for blood biomarkers in hypertension, necessitating future research to establish cutoffs for improved risk stratification.
Absolute Event Rate: 0% vs 0%
Regarding the risk stratification of physiological vascular tests in hypertensive patients, while some hypertension guidelines provide cutoff values for physiological tests, the reference values for blood biomarkers are not clearly defined. Future evidence on the contribution of vascular biomarker measurements to improve outcome in hypertensive patients is expected, including the establishment of appropriate cutoff values based on large studies of blood biomarkers and future evidence on cardio-ankle vascular index.
Tomoyuki Kabutoya (Wed,) reported a other. Future studies are needed to establish cutoff values for vascular biomarkers that could improve cardiovascular outcomes in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: